Helicobacter pylori DNA and bacterial cell integrity — Drug Target

All drugs that target Helicobacter pylori DNA and bacterial cell integrity — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Antibiotic combination therapy

Marketed (1)

• metronidazole based quadriple therapy · mohamed bouchoucha · Antibiotic combination therapy · Gastroenterology / Infectious Disease
  Metronidazole-based quadruple therapy combines metronidazole with three other agents (typically a proton pump inhibitor, bismuth compound, and tetracycline or clarithromycin) to eradicate Helicobacter pylori through multiple antimicrobial and acid-suppressive mechanisms.